• Title/Summary/Keyword: Ovarian diseases

Search Result 94, Processing Time 0.026 seconds

Computed Tomographic Features of Canine Ovarian Masses

  • Hong, Sae-Byel;Choi, Ho-Jung;Lee, Young-Won
    • Journal of Veterinary Clinics
    • /
    • v.39 no.3
    • /
    • pp.107-113
    • /
    • 2022
  • This paper describes the computed tomographic features of ovarian masses in dogs. The CT images of female dogs with a confirmed histological diagnosis of ovarian tumors or ovarian cystic diseases were studied retrospectively. Seven dogs met the inclusion criteria. The morphological features of ovarian tumors and ovarian cystic diseases coincided to a certain degree, but ovarian tumors tended to be predominantly solid. Objective measurements of Hounsfield units (HU) suggest that benign lesions may show lower HU values than malignant tumors and mild contrast enhancement because of the small soft tissue composition. CT is useful for a differential diagnosis of ovarian masses by providing additional information on the imaging features of the masses and an evaluation of metastases.

Therapeutic Effect of Prostaglandin $F_{2a}$ on Cows with Ovarian Disease (Prostaglandin $F_{2a}$에 의한 유우난소질환의 치료효과)

  • Kang Byong-Kyu;Choi Sang-Gong
    • Journal of Veterinary Clinics
    • /
    • v.3 no.2
    • /
    • pp.317-324
    • /
    • 1986
  • A total of 600 Holstein cows in Chonnam province were examined to make a diagnosis on the ovarian diseases. By clinical signs and rectal examinations, 120 cows were founded to have ovarian diseases such as 40 cows with suboestrus, 40 cows with persistent corpus luteum, 40 cows with luteal cysts. The Prostaglandin $F_{2{\alpha}}$ (PG $F_{2{\alpha}}$) was administered intramuscularly and intradermic vaginally ; also intraovarian injections and intrauterine infusions was made. Comparisons were made on the effect of PG $F_{2{\alpha}}$ on the ovarian diseases. The results obtained were summarized as follows. 1. Induction of normal estrum after PG $F_{2{\alpha}}$ treatment was 75.0~82.5%(mean 78.3%). The conception rate was 83.3~84.8% (mean 84.0%) and average services per conception was 1.6~l.8(mean 1.7). Days from treatment to estrum was 3.9~4.3(mean 4.1) days. 2. Average conception rate was different according to the routes of administration: intraovary 91.7%, intra-uterus 88.0%, intramuscle 80.9% and intradermic vagina 75.0%, respectively.

  • PDF

Ovarian Cancer in Iranian Women, a Trend Analysis of Mortality and Incidence

  • Sharifian, Abdolhamid;Pourhoseingholi, Mohamad Amin;Norouzinia, Mohsen;Vahedi, Mohsen
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.15 no.24
    • /
    • pp.10787-10790
    • /
    • 2015
  • Background: Ovarian cancer is an important cause of mortality in women. The aim of this study was to evaluate the incidence and mortality rates and trends in the Iranian population and make predictions. Materials and Methods: National incidence from Iranian annual of National Cancer Registration report from 2003 to 2009 and National Death Statistics reported by the Ministry of Health and Medical Education from 1999 to 2004 were included in this study. A time series model (autoregressive) was used to predict the mortality for the years 2007, 2008, 2012 and 2013, with results expressed as annual mortality rates per 100,000. Results: The general mortality rate of ovarian cancer slightly increased during the years under study from 0.01 to 0.75 and reaching plateau according to the prediction model. Mortality was higher for older age. The incidence also increased during the period of the study. Conclusions: Our study indicated remarkable increasing trends in ovarian cancer mortality and incidence. Therefore, attention to high risk groups and setting awareness programs for women are needed to reduce the associated burden in the future.

A Case of Metastatic Tracheal Tumor From Ovarian Carcinoma (악성 난소암에서 전이된 기관 종양 1예)

  • Choi, Cheon-Woong;Yoo, Jee-Hong;Oh, Hye-Lim;Cho, Yong-Seon;Kang, Hong-Mo
    • Tuberculosis and Respiratory Diseases
    • /
    • v.50 no.4
    • /
    • pp.499-503
    • /
    • 2001
  • Tracheal tumors are uncommon comprising less than 0.1% of all malignancies. Metastatic tracheal tumors, especially from the extrathoracic sites, are exceedingly rare. Ovarian cancer tends to metastasize to the serous cavities and the lymph nodes. One large autopsy study reported tracheal involvement in 1% of patients who had died from ovarian cancer. Other studies have not mentioned tracheal involvement at all. Since the main symptoms of cough, hemoptysis, or wheezing are nonspecific, patients may be initially treated for other conditions including asthma or bronchitis. Here we describe a metastatic tracheal tumor from an ovarian carcinoma that was initially treated for bronchial asthma.

  • PDF

Pathway Crosstalk Analysis Based on Protein-protein Network Analysis in Ovarian Cancer

  • Pan, Xiao-Hua
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.13 no.8
    • /
    • pp.3905-3909
    • /
    • 2012
  • Ovarian cancer is the fifth leading cause of cancer death in women aged 35 to 74 years. Although there are several popular hypothesis of ovarian cancer pathogenesis, the genetic mechanisms are far from being clear. Recently, systems biology approaches such as network-based methods have been successfully applied to elucidate the mechanisms of diseases. In this study, we constructed a crosstalk network among ovarian cancer related pathways by integrating protein-protein interactions and KEGG pathway information. Several significant pathways were identified to crosstalk with each other in ovarian cancer, such as the chemokine, Notch, Wnt and NOD-like receptor signaling pathways. Results from these studies will provide the groundwork for a combination therapy approach targeting multiple pathways which will likely be more effective than targeting one pathway alone.

Subsequent Oophorectomy and Ovarian Cancer after Hysterectomy for Benign Gynecologic Conditions at Chiang Mai University Hospital

  • Jitkunnatumkul, Aurapin;Tantipalakorn, Charuwan;Charoenkwan, Kittipat;Srisomboon, Jatupol
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.17 no.8
    • /
    • pp.3845-3848
    • /
    • 2016
  • This study was undertaken to determine the incidence of subsequent oophorectomy due to ovarian pathology or ovarian cancer in women with prior hysterectomy for benign gynecologic conditions at Chiang Mai University Hospital. Medical records of women who underwent hysterectomy for benign gynecologic diseases and precancerous lesions between January 1, 2004 and December 31, 2013 at Chiang Mai University Hospital were retrospectively reviewed. The incidence and indications of oophorectomy following hysterectomy were analyzed. During the study period, 1,035 women had hysterectomy for benign gynecologic conditions. Of these, 590 women underwent hysterectomy with bilateral salpingo-oophorectomy and 445 hysterectomy with bilateral ovarian preservation or unilateral salpingo-oophorectomy. The median age was 47 years (range, 11-75 years). Ten women (2.45 %) had subsequent oophorectomy for benign ovarian cysts. No case of ovarian cancer was found. The mean time interval between hysterectomy and subsequent oophorectomy was 43.1 months (range, 2-97 months) and the mean follow-up time for this patient cohort was 51 months (range, 1.3-124.9 months). According to our hospital-based data, the incidence of subsequent oophorectomy in women with prior hysterectomy for benign gynecologic conditions is low and all represent benign conditions.

A case of ovarian enterobiasis

  • Hong, Sung-Tae;Choi, Min-Ho;Chai, Jong-Yil;Kim, Young-Tak;Kim, Mi-Kyung;Kim, Kyu-Rae
    • Parasites, Hosts and Diseases
    • /
    • v.40 no.3
    • /
    • pp.149-151
    • /
    • 2002
  • A 36-year old Korean woman consulted a clinic for a regular gynecological examination, and a mass was noticed in her pelvis. She was referred to the Asan Medical Center, Seoul where transvaginal ultrasonography confirmed a pelvic mass exceeding 10cm in diameter. She received total abdominal hysterectomy and bilateral salpingoophorectomy, and a borderline serous neoplasm with micropapillary features involving the left ovary and right ovarian serosa was histopathologically confirmed. In addition, a section of a nematode with numerous eggs was found in the parenchyma of the left ovary. The worm had degenerated but the eggs were well-preserved and were identified as those of Enterobius vermicularis. She is an incidentally recognized case of ovarian enterobiasis.

Body composition: A predictive factor of cycle fecundity

  • Kayatas, Semra;Boza, Aysen;Api, Murat;Kurt, Didar;Eroglu, Mustafa;Arinkan, Sevcan Arzu
    • Clinical and Experimental Reproductive Medicine
    • /
    • v.41 no.2
    • /
    • pp.75-79
    • /
    • 2014
  • Objective: To study the effect of body composition on reproduction in women with unexplained infertility treated with a controlled ovarian hyperstimulation and intrauterine insemination programme. Methods: This prospective observational study was conducted on 308 unexplained infertile women who were scheduled for a controlled ovarian hyperstimulation and intrauterine insemination programme and were grouped as pregnant and non-pregnant. Anthropometric measurements were performed using TANITA-420MA before the treatment cycle. Body composition was determined using a bioelectrical impedance analysis system. Results: Body fat mass was significantly lower in pregnant women than in non-pregnant women ($15.61{\pm}3.65$ vs. $18.78{\pm}5.97$, respectively) (p=0.01). In a multiple regression analysis, body fat mass proved to have a stronger association with fecundity than the percentage of body fat, body mass index, or the waist/hip ratio (standardized regression coefficient${\geq}0.277$, t-value ${\geq}2.537$; p<0.05). The cut-off value of fat mass, which was evaluated using the receiver operating characteristics curve, was 16.65 with a sensitivity of 61.8% and a specificity of 70.2%. Below this cut-off value, the odds of the pregnancy occurrence was found to be 2.5 times more likely. Conclusion: Body fat mass can be predictive for pregnancy in patients with unexplained infertility scheduled for a controlled ovarian hyperstimulation and intrauterine insemination programme.

Endometriosis, Leiomyoma and Adenomyosis: the Risk of Gynecologic Malignancy

  • Verit, Fatma Ferda;Yucel, Oguz
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.14 no.10
    • /
    • pp.5589-5597
    • /
    • 2013
  • The aim of this review article was to evaluate the relationship and the possible etiological mechanisms between endometriosis, leiomyoma (LM) and adenomyosis and gynecological cancers, such as ovarian and endometrial cancer and leiomyosarcoma (LMS). MEDLINE was searched for all articles written in the English literature from July 1966 to May 2013. Reports were collected systematically and all the references were also reviewed. Malignant transformation of gynecologic benign diseases such as endometriosis, adenomyosis and LM to ovarian and endometrial cancer remains unclear. Hormonal factors, inflammation, familial predisposition, genetic alterations, growth factors, diet, altered immune system, environmental factors and oxidative stress may be causative factors in carcinogenesis. Early menarche, low parity, late menopause and infertility have also been implicated in the pathogenesis of these cancers. Ovarian cancers and endometriosis have been shown to have common genetic alterations such as loss of heterozygosity (LOH), PTEN, p53, ARID1A mutations. MicroRNAs have also been implicated in malignant transformation. Inflammation releases proinflammatory cytokines, and activates tumor associated macrophages (TAMS) and nuclear factor kappa b (NF-KB) signaling pathways that promote genetic mutations and carcinogenesis. MED12 mutations in LM and smooth muscle tumors of undetermined malignant potential (STUMP) may contribute to malignant transformation to LMS. A hyperestrogenic state may be shared in common with pathogenesis of adenomyosis, LM and endometrial cancer. However, the effect of these benign gynecologic diseases on endometrial cancer should be studied in detail. This review study indicates that endometriosis, LM, adenomyosis may be associated with increased risk of gynecological cancers such as endometrial and ovarian cancers. The patients who have these gynecological benign diseases should be counseled about the future risks of developing cancer. Further studies are needed to investigate the relationship between STUMPs, LMS and LM and characteristics and outcome endometrial carcinoma in adenomyotic patients.

New Insights into mTOR Signal Pathways in Ovarian-Related Diseases: Polycystic Ovary Syndrome and Ovarian Cancer

  • Liu, Ai Ling;Liao, Hong Qing;Li, Zhi Liang;Liu, Jun;Zhou, Cui Lan;Guo, Zi Fen;Xie, Hong Yan;Peng, Cui Ying
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.17 no.12
    • /
    • pp.5087-5094
    • /
    • 2016
  • mTOR, the mammalian target of rapamycin, is a conserved serine/threonine kinase which belongs to the phosphatidyl-linositol kinase-related kinase (PIKK) family. It has two complexes called mTORC1 and mTORC2. It is well established that mTOR plays important roles in cell growth, proliferation and differentiation. Over-activation of the mTOR pathway is considered to have a relationship with the development of many types of diseases, including polycystic ovary syndrome (PCOS) and ovarian cancer (OC). mTOR pathway inhibitors, such as rapamycin and its derivatives, can directly or indirectly treat or relieve the symptoms of patients suffering from PCOS or OC. Moreover, mTOR inhibitors in combination with other chemical-molecular agents may have extraordinary efficacy. This paper will discuss links between mTOR signaling and PCOS and OC, and explore the mechanisms of mTOR inhibitors in treating these two diseases, with conclusions regarding the most effective therapeutic approaches.